Join the West Virginia Clinical and Translational Science Institute for a special event on Thursday, October 29, from 11 a.m. to 1 p.m. discussing COVID-19 policy and public health and cutting edge research in West Virginia.
The event will be divided into two segments. The first segment will begin at 11 a.m. focusing on policy and public health. The second segment will begin at noon and turn towards specific research projects that look at managing the pandemic and treating COVID-19 in new and novel ways.
Pre-registration is required for ZOOM connection info. Visit the event webpage for more information and to register.
PART 1: Focus on Policy and Public Health
This session will include comments from Dr. Anthony Fauci, who is one of the nation's leading experts in infectious disease, along with Dr. Clay Marsh, West Virginia's COVID-19 czar. The event will be moderated by Sally Hodder, MD, associate vice president of clinical and translational research at West Virginia University and director of WVCTSI.
- Anthony S. Fauci, MD, Director, National Institute on Allergy and Infectious Disease
- Bill J. Crouch, Secretary, West Virginia Department of Health and Human Resources
- Clay B. Marsh, MD, West Virginia COVID-19 Czar; Vice President and Executive Dean, West Virginia University Health Sciences
PART 2: Cutting Edge Research in West Virginia
Three presenters will discuss their West Virginia-led COVID-19 research projects:
- F. Heath Damron, PhD, Assistant Professor and Director of the Vaccine Development Center, WVU Health Sciences
- Brian Hendricks, PhD, Research Assistant Professor, Department of Epidemiology, School of Public Health, WVU
- Ali Rezai, MD, FAANS, Executive Chair, Vice President of Neuroscience; Associate Dean, John D. Rockefeller IV tenured professor in neuroscience, School of Medicine, WVU
A video recording will be available after the event for those unable to attend in-real-time.